Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
13% Non-GAAP and 26% GAAP Diluted EPS Growth Over Prior Year;
TYSABRI
In-Market Sales Exceeded $1 Billion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the
discovery, development, manufacturing, and commercialization of
innovative therapies, today announced its full year and fourth quarter
2009 results.
Full Year 2009 Highlights:
-- Total revenues in 2009 were $4.4 billion, an increase of 7% versus 2008.
The increase was driven primarily by the continued growth of ...
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6739433
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6739341
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6736565
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will serve on the Board's Audit Committee. Dr. Kostas was appointed as the representative of entities affiliated with Carl C. Icahn. "We are delighted to welcome Odysseas to our Board of Directors," said Jack Lief, Chair of the ADVENTRX Board of Directors and the Board's Audit Committee. "His insights should prove valuable as we advance our product candidates towards commercialization." Dr. Kostas, M.D. is an attending physician and one of seven hospitalists at Greenwich Hospital, a member of the Yale New Haven Health System and a subsidiary of Greenwich Health ...
-
Form SC 13D/A BLOCKBUSTER INC Filed by: ICAHN CARL C
-
Robert D. Joffe, Trusted Adviser to Leading Companies and Former Leader of Cravath, Swaine & Moore LLP, Dies at 66
-
Take-Two (TTWO) volatility low at 54
-
Icahn Boosts Stake in Take-Two (TTWO) to 12.3%
-
Form 4 TAKE TWO INTERACTIVE For: Jan 26 Filed by: ICAHN CARL C
-
Form 4 TAKE TWO INTERACTIVE For: Jan 26 Filed by: ICAHN CARL C
-
Form SC 13D/A TAKE TWO INTERACTIVE Filed by: ICAHN CARL C
-
Form SC 13D/A BIOGEN IDEC INC. Filed by: ICAHN CARL C
-
Icahn Plans to Nominate Three To Biogen Idec (BIIB) Board
-
Biogen Idec Receives Notice of Intention to Nominate Directors at 2010 Meeting of Shareholders
-
Form 4 TAKE TWO INTERACTIVE For: Jan 21 Filed by: ICAHN CARL C
-
Form SC 13D/A AMYLIN PHARMACEUTICALS Filed by: ICAHN CARL C
-
Forest Labs (FRX) Developing Drugs, and Potential Profits, for Investors - Barron's
-
Form SC 13D/A TAKE TWO INTERACTIVE Filed by: ICAHN CARL C
-
Take-Two Interactive Software, Inc. to Nominate Three New Directors at 2010 Annual Meeting
-
Standpoint Research Initiates Coverage on Biogen Idec (BIIB) with a Buy
-
Form 4 ICAHN ENTERPRISES L.P. For: Jan 15 Filed by: ICAHN CARL C
-
Form 4 American Railcar Industr For: Jan 15 Filed by: ICAHN CARL C
-
Form SC 13D/A American Railcar Industr Filed by: ICAHN CARL C
-
Form SC 13D/A ICAHN ENTERPRISES L.P. Filed by: ICAHN CARL C
-
Form 8-K ICAHN ENTERPRISES L.P. For: Jan 12
-
Icahn Enterprises Announces Closing of $2.0 Billion Senior Notes Offering and Acquisitions of Interests of American Railcar Industries and Viskase Companies
-
Genzyme (GENZ) Not in Talks With Icahn - DJN
-
Icahn Enterprises Announces Expiration of Consent Payment Deadline for Tender Offers and Consent Solicitations and Execution of Supplemental Indentures Relating to Its Existing 8.125% Senior Notes Due
-
Form 8-K ICAHN ENTERPRISES L.P. For: Jan 08
-
Activist investor Carl Icahn may launch proxy battle at Genzyme Corp (GENZ) - Reuters
-
Icahn Enterprises Announces Supplement to Tender Offers and Consent Solicitations for its Existing 8.125% Senior Notes Due 2012 and 7.125% Senior Notes Due 2013
-
Form 4 XO HOLDINGS INC For: Dec 31 Filed by: ICAHN CARL C
-
Form SC 13D/A XO HOLDINGS INC Filed by: ICAHN CARL C
-
Form 8-K ICAHN ENTERPRISES L.P. For: Dec 30
-
Icahn Enterprises (IEP) Plans to Offer $2B in New Debt
-
Icahn Enterprises Announces Cash Tender Offers and Consent Solicitations for Its Existing 8.125% Senior Notes Due 2012 and 7.125% Senior Notes Due 2013; Icahn Enterprises Also Announces Intention to R
-
Icahn Enterprises L.P. Intends to Offer New Senior Debt
-
Take-Two Interactive (TTWO) Options Limited Going Into FY10 - Barron's
-
Take-Two (TTWO) Jan volatility elevated at 69, February at 64
-
Form SC 13G CIT GROUP INC Filed by: ICAHN CARL C
-
Icahn Discloses 11.3% Stake in Take-Two (TTWO), Says Shares Undervalued
-
Form SC 13D TAKE TWO INTERACTIVE Filed by: ICAHN CARL C
-
Icahn Outbids Penn National Gaming (PENN) On Bankrupt Fontainebleau Casino Project
-
Carl Icahn Takes a Stab At Beaten-Up Genzyme (GENZ), Can He Spark a Rally
-
Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
-
David Faber expects CIT (CIT) will still file prepackaged bankruptcy by Monday, even after Icahn deal - CNBC
-
CIT Group (CIT) Enters Agreement With Carl Icahn, Obtains $1B Line of Credit
-
CIT, Icahn reach a tentative deal on restructuring. Icahn will provide a $1 billion backup line to CIT - wsj
-
Unusual 11 Mid-Day Movers 10/28: CTS, QTM, KWR, CIT, NTRI Higher; KSP, CALC, PSYS, ILMN Lower
-
CIT Jumps 12% on Financing News
-
CIT gets added $4.5B in financing from lenders, not from Icahn
-
Icahn Provides CIT Commitment Letter for $4.5B Term Loan; Requests Acceptance by 6pm This Evening
-
Icahn Says CIT Bondholder's Treatment is 'An Example of What's Wrong with the Bankruptcy System'
-
Icahn Says Goodbye To Yahoo!'s (YHOO) Board
